BiliaryTractCancer near Englewood, NJ
We found 476 results within 5 miles for "BiliaryTractCancer near Englewood, NJ"
- Appt. wasn't rushed (39)
- Listened/answered questions (39)
- Explains conditions well (39)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (38)
- Listened/answered questions (38)
- Explains conditions well (38)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: I'm enthusiastic about providing each and every patient with the right treatment at the right time. I specialize in helping people with arthritic disorders of the hip and knee. After first attempting to treat you without surgery, it would be my pleasure to perform your primary knee or hip replacement or correct a failed or infected joint replacement. I'm also skilled at partial knee replacements, a much less invasive approach to treating knee arthritis before it has progressed to an advanced stage.

- Listened/answered questions (20)
- Explains conditions well (20)
- Found trustworthy (20)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Iwamoto is a neuro-oncologist whose previous training includes a neurology residency at NewYork-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke, in Bethesda, MD. At the intramural NIH, Dr. Iwamoto was a principal investigator in early phase clinical trials for brain tumors and worked with laboratory and computational scientists on several translational projects in brain tumors. Dr. Iwamoto was recruited to Columbia University as the Deputy Director of the Neuro-oncology Division and is actively developing the clinical and translational research components of this program. He is an expert in the diagnosis, management, and treatment of brain and spinal cord tumors as well as neurological complications of cancer.

- Appt. wasn't rushed (21)
- Listened/answered questions (21)
- Explains conditions well (21)
- View 1 more provider attributes
- Offers Telehealth
Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

- Found trustworthy (27)
- Appt. wasn't rushed (26)
- Listened/answered questions (26)
- View 2 more provider attributes
- Offers Telehealth
Biography: Dr. James Lee is an internationally recognized endocrine surgeon who specializes in the care of patients with thyroid, parathyroid, and adrenal disorders. Dr. Lee is the Chief of Endocrine Surgery and the Edwin K. and Anne C. Weisskopf Professor of Surgical Oncology at Columbia University and the Physician Director of the Endocrine Service Line at the NY Presbyterian Hospital. He serves as Co-Director of the multidisciplinary Columbia Thyroid Center, Parathyroid Center, and Adrenal Center. He has been rated as one of the Best Doctors in America and is one of the highest volume endocrine surgeons in the country. Dr. Lee received his medical degree from Columbia University's College of Physicians and Surgeons, completed his residency in General Surgery at Columbia and went on to a fellowship in Endocrine Surgery at the University of California, San Francisco. Dr. Lee is actively involved in the leadership of Endocrine Surgery at the national and international level. He serves on the Executive Council of the American Association of Endocrine Surgeons and Standing Faculty of the international Endocrine Surgery University. He co-created the inaugural Postgraduate Course in Endocrine Surgery at the American College of Surgeons and is a featured lecturer in the biannual Masters of Endocrine Surgery Course. He has authored over 100 articles and book chapters, including the AAES Parathyroidectomy Guidelines which sets the international standard for the care of patients with parathyroid disease. He is also the Co-Editor of Surgical Endocrinopathies and the Founding Figures which details state of the art care for patients with endocrine disorders as well as the rich history of discovery in the field. Dr. Lee has given over 100 invited lectures and visiting professorships at institutions around the world. He has travelled extensively to teach other endocrine surgeons advanced techniques such as minimally invasive thyroid and parathyroid surgery as well as laparoscopic retroperitoneal adrenalectomy. He has mentored dozens of clinical and research fellows over his career, many of whom are now leaders in their own institutions and abroad. Dr. Lee also serves as the Vice Chair of New Media in the Columbia University Department of Surgery and Chair of the ColumbiaDoctors Communications Committee. In this role, he oversees the digital strategy for multiple groups across the medical center with the mission of providing the highest quality education on health and wellness to the global audience.

- Explains conditions well (18)
- Found trustworthy (18)
- Appt. wasn't rushed (17)
- View 2 more provider attributes
- Offers Telehealth

- Listened/answered questions (11)
- Explains conditions well (11)

- Listened/answered questions (10)
- Explains conditions well (10)
- Found trustworthy (4)
- View 2 more provider attributes
- Offers Telehealth

- Explains conditions well (95)
- Listened/answered questions (94)
- Found trustworthy (94)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (15)
- Listened/answered questions (15)
- Explains conditions well (15)
- View 2 more provider attributes
- Offers Telehealth
Biography: Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center.

- Listened/answered questions (21)
- Found trustworthy (20)
- Explains conditions well (18)
- View 2 more provider attributes
- Offers Telehealth
Biography: Dina Podolsky, MD, is an Assistant Professor of Surgery at Columbia University Irving Medical Center. She is a board-certified general surgeon who graduated with honors from Rutgers University, where she also received her medical degree, and completed a residency in general surgery at Montefiore Medical Center. Dr. Podolsky then completed fellowship training in complex abdominal wall reconstruction and robotic surgery at Columbia University Irving Medical Center, where she worked closely with one of the world's leading hernia surgeons, Dr. Novitsky. She is a member of several national organizations, including the Americas Hernia Society and the Society of American Gastrointestinal and Endoscopic Surgeons. Dr. Podolsky has received numerous awards for her training and teaching, including the Leo M. Davidoff Award for Outstanding Teaching and the Golden Apple Teaching Award. Dr. Podolsky specializes in all aspects of hernia surgery, including inguinal, ventral, and complex abdominal wall reconstruction, employing minimally invasive techniques with laparoscopic and robotic surgery. She has presented research at major professional associations and continues to be active in research, publishing both academic research and textbook chapters. Dr. Podolsky currently sees patients in midtown Manhattan and Washington Heights.

- Listened/answered questions (33)
- Appt. wasn't rushed (32)
- Explains conditions well (32)
- View 2 more provider attributes

- Appt. wasn't rushed (22)
- Listened/answered questions (22)
- Explains conditions well (22)
- View 2 more provider attributes
- Offers Telehealth

- Explains conditions well (83)
- Found trustworthy (83)
- Listened/answered questions (82)
- View 2 more provider attributes

- Found trustworthy (10)

- Listened/answered questions (17)
- Explains conditions well (17)
- Appt. wasn't rushed (16)
- View 1 more provider attributes

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

- Listened/answered questions (22)
- Explains conditions well (22)
- Found trustworthy (22)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon's Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.

- Felt Respected (4)
- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes

- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 2 more provider attributes
- Offers Telehealth
Biography: Jason Hawksworth, MD is a noted pioneer in minimally invasive robotic hepatobiliary and transplant surgery. Dr. Hawksworth is the Surgical Director of Adult Liver Transplantation, Chief of Hepatobiliary Surgery, and the Director of Robotic Liver Surgery Program in the Division of Abdominal Organ Transplant and Hepatobiliary Surgery at New York Presbyterian Hospital/Columbia University Irving Medical Center and is an Associate Professor at Columbia University College of Physicians and Surgeons. Dr. Hawksworth is known for unique and innovative minimally invasive robotic surgeries to remove tumors of the liver, bile duct and pancreas, including robotic major hepatectomy, robotic pancreatectomy, and robotic Whipple. He also specializes in robotic transplantation including robotic kidney transplantation, robotic living donor nephrectomy and robotic living donor hepatectomy. Dr. Hawksworth received his undergraduate degree from The United States Military Academy at West point and his medical degree from Wake Forest University Bowman Gray School of Medicine. Dr. Hawksworth completed general surgery residency at Walter Reed Army Medical Center followed by an abdominal transplant and hepatobiliary surgery fellowship at Georgetown University Hospital. Previously the Chief of Robotic Surgery at Georgetown University Hospital, Dr. Hawksworth established one of the nation's premier robotic hepatobiliary and transplant programs in 2018 at Georgetown. He was recruited to Columbia University Irving Medical Center in 2023 to lead the liver transplant and hepatobiliary programs and continue to develop innovative techniques in robotic surgery. Dr. Hawksworth is a member of several key organizations including a Fellow of the American College of Surgeons, American Society of Transplant Surgeons, International Laparoscopic Liver Society, and Americas Hepato-Pancreato-Biliary Association. His research interests include clinical transplant and hepatobiliary trials, and he has published over 60 scientific manuscripts and book chapters in leading journals such as Annals of Surgery, Journal of Gastrointestinal Surgery, American Journal of Transplantation and Transplantation. Dr. Hawksworth is a Colonel in the Army reserves and has deployed four times to support combat operations in Afghanistan and the Middle East. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver.
